News Daily News FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease Caitlin E. Cox October 05, 2018
News Conference News TCT 2018 Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released Todd Neale September 24, 2018
News Daily News CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence Caitlin E. Cox September 05, 2018
News Daily News ‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions Yael L. Maxwell August 17, 2018
News Daily News High-Risk Medical Device Approval Process in Europe Inches Towards Transparency Michael O'Riordan July 20, 2018
News Daily News Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval Michael O'Riordan May 08, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Conference News ACC 2018 Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues Michael O'Riordan March 11, 2018
News Daily News FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market Yael L. Maxwell February 26, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News FDA Grants HeartWare LVAD a Destination Therapy Indication Todd Neale September 28, 2017
News Daily News FDA Clears Sentinel Cerebral Protection Device for Use During TAVR Shelley Wood June 05, 2017
News Daily News FDA Gives Thumbs Up to Side Branch Stent for Bifurcation Lesions Todd Neale March 06, 2017
News Daily News La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes Yael L. Maxwell October 28, 2016
News Daily News FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke Yael L. Maxwell October 28, 2016
News Daily News TAVR as an Option for Intermediate-Risk Patients: Physicians Respond Yael L. Maxwell August 24, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016